The use of combination chemotherapy to cure acute lymphoblastic leukemia in children and acute myeloid leukemia in adults emerged for acute myeloid leukemia in the 1960s and for acute lymphoblastic leukemia in the 1980s as a paradigm for curing any disseminated cancer. This article summarizes recent developments and considerations in the use of acute leukemia xenografts established in immunodeficient mice to elucidate the genetic and genomic basis of acute leukemia pathogenesis and treatment response.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2217/pgs.12.158 | DOI Listing |
Publication Analysis
Top Keywords
acute leukemia
12
acute lymphoblastic
8
lymphoblastic leukemia
8
acute myeloid
8
myeloid leukemia
8
acute
7
leukemia
7
pharmacogenomic considerations
4
considerations xenograft
4
xenograft mouse
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!